Alimera Sciences Inc

Ownership Transactions Reported by 24 Insiders

Symbol
ALIM on Nasdaq
Industry
Pharmaceutical Preparations
Location
6310 Town Square, Suite 400, Alpharetta, Georgia

There are no Buy or Sell transactions made by insiders since 9/11/2023

Alimera Sciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Caligan Partners LP 10%+ Owner $120M $0 0% Sep 14, 2023
Adam Morgan Director, 10%+ Owner $52.5M Oct 2, 2023
Velan Capital Investment Management LP 10%+ Owner $6.41M May 17, 2023
Richard S. Eiswirth Jr President and CEO $2.85M Mar 11, 2024
Morgan Stanley 10%+ Owner $2.15M Feb 8, 2022
Todd Wood President of U.S. Operations $965K Mar 11, 2024
Jason Werner Chief Operating Officer $876K Mar 11, 2024
Philip Ashman President of Int'l Operations $769K Mar 26, 2024
Elliot Maltz Chief Financial Officer $579K Mar 11, 2024
David Holland Chief Marketing Officer & SVP $424K Nov 21, 2023
Russell Skibsted Chief Financial Officer & SVP $292K Nov 21, 2023
John Philip Jones Chief Financial Officer $124K Oct 31, 2022
Palo Alto Investors LP 10%+ Owner Mar 24, 2023
Roger Sawhney Director Feb 25, 2023
Ross D. DeMont Director Oct 2, 2023
C. Daniel Myers Chairman Emeritus Aug 1, 2023
James R. Largent Director Jan 4, 2023
Michael Kaseta Director Oct 2, 2023
Garheng Kong Director Jan 4, 2023
Margaret Pax Director Nov 7, 2023
Peter J. Pizzo III Director Oct 2, 2023
Erin Parsons Director Oct 2, 2023
John Snisarenko Director Oct 2, 2023
Brian K. Halak Director Jan 4, 2023

Recent Insider Transactions by Companies or Individuals for Alimera Sciences Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.